X线子宫输卵管造影与3特斯拉磁共振子宫输卵管造影在女性不孕症输卵管通畅性评估中的比较
本研究纳入19例不孕症患者,在同一次置管下同时行X线子宫输卵管造影(XR-HSG)和3T磁共振子宫输卵管造影(MR-HSG),两者对输卵管通畅性的诊断一致(15例双侧通畅、4例单侧通畅),但MR-HSG额外检出附件区子宫内膜异位病灶、子宫腺肌症、单角子宫畸形、黏膜下肌瘤及卵巢储备下降等,并发现MR-HSG疼痛更轻。
要点
- XR-HSG与MR-HSG对输卵管通畅性的诊断结果一致,均为15例双侧通畅、4例单侧通畅。
- MR-HSG可额外检出附件区子宫内膜异位病灶、子宫腺肌症、单角子宫畸形、黏膜下肌瘤及卵巢储备下降等。
- 仅用XR-HSG时约30%女性可能为假阴性;问卷显示MR-HSG较XR-HSG疼痛更轻。
核心结论
- XR-HSG与MR-HSG在评估输卵管通畅性方面诊断相同,MR-HSG还能检出可能成为治疗靶点的其他伴随发现,并可能成为女性不孕症诊断的新金标准。
研究设计与样本
- 研究纳入19例30至42岁(平均年龄37.7岁)不孕症患者,在同一次置管下同时行XR-HSG和MR-HSG,动态MR-HSG包括经宫颈导管注射对比剂期间采集MR序列。
关键影像表现/征象
- XR-HSG与MR-HSG均显示19例中15例双侧输卵管通畅、4例单侧输卵管通畅。
- MR-HSG额外诊断附件区两个活动性子宫内膜异位病灶及子宫腺肌症。
- MR-HSG额外诊断单角子宫畸形。
- MR-HSG额外诊断靠近输卵管口的黏膜下子宫肌瘤。
- MR-HSG额外诊断一例患者卵巢储备下降。
临床应用与阅片要点
- MR-HSG在10/19(52%)女性中可能检出不孕原因,而XR-HSG检出4/19(21%)。
- 若仅使用XR-HSG,约30%女性可能为假阴性。
- 问卷显示MR-HSG较XR-HSG疼痛更轻。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: XR-hysterosalpingography currently represents the gold standard for tubal pathology evaluation. Magnetic resonance-HSG is an innovative technique. With our study, we aim to comprehend if and how MR-HSG, compared to traditional XR-HSG, could give us this additional information in the diagnostic/therapeutic process.
MATERIALS AND METHODS: This study included 19 patients between 30 and 42 years old (average age 37.7) affected by infertility. Patients underwent contextually both XR-HSG and MR-HSG, using a single catheterization. The dynamic MR-HSG exam consisted a MR sequence during contrast administration through the cervical catheter.
RESULTS: Both XR-HSG and MR-HSG documented that 15 of the 19 patients had bilateral tubal patency, while four patients had monolateral tubal patency. However, MR-HSG allowed us to diagnose additional findings: Two active endometriosis foci in adnexal localization and a condition of adenomyosis A unicornuate uterus malformation A submucous uterine myoma near the tubal ostium A decrease of the ovarian reserve in a patient So MR-HSG could potentially detect in 10/19 (52%) women the cause of their infertility, compared to 4/19 (21%) detected with XR-HSG and about 30% of women would have resulted as false negatives if we only used XR-HSG. Finally, with a questionnaire, we demonstrated that MR-HSG is less painful than XR-HSG.
CONCLUSIONS: These data thus confirm that XR-HSG and MR-HSG present the same diagnostic of assessing tubal patency. We also demonstrated that MR-HSG is able to detect further collateral findings that could likewise be a possible therapeutic target and it could possibly become the new gold standard in female infertility diagnostics.
引用
- Pace C, Argirò R, Casadei L, et al. Comparison between X-ray-hysterosalpingography and 3 Tesla magnetic resonance-hysterosalpingography in the assessment of the tubal patency in the cause of female infertility. Radiol Med. 2022. PMID: 36167884. doi:10.1007/s11547-022-01556-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。